550 related articles for article (PubMed ID: 22425584)
21. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.
Oh S; Shin S; Lightfoot SA; Janknecht R
Cancer Res; 2013 Aug; 73(16):5110-9. PubMed ID: 23774214
[TBL] [Abstract][Full Text] [Related]
22. ETS factors in prostate cancer.
Qian C; Li D; Chen Y
Cancer Lett; 2022 Apr; 530():181-189. PubMed ID: 35033589
[TBL] [Abstract][Full Text] [Related]
23. Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.
Qi T; Qu Q; Li G; Wang J; Zhu H; Yang Z; Sun Y; Lu Q; Qu J
Am J Cancer Res; 2020; 10(10):3083-3105. PubMed ID: 33163259
[TBL] [Abstract][Full Text] [Related]
24. Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression.
Alder D; Braun M; Nikolov P; Boehm D; Scheble V; Menon R; Fend F; Kristiansen G; Perner S; Wernert N
Hum Pathol; 2012 Nov; 43(11):1910-6. PubMed ID: 22569213
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial.
Palanisamy N; Tsodikov A; Yan W; Suleman K; Rittmaster R; Lucia SM; Chinnaiyan AM; Fleshner N; Kunju LP
Urol Oncol; 2015 Mar; 33(3):108.e5-13. PubMed ID: 25175425
[TBL] [Abstract][Full Text] [Related]
26. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa.
Dissanayake K; Toth R; Blakey J; Olsson O; Campbell DG; Prescott AR; MacKintosh C
Biochem J; 2011 Feb; 433(3):515-25. PubMed ID: 21087211
[TBL] [Abstract][Full Text] [Related]
27. The transcription factors Etv4 and Etv5 mediate formation of the ureteric bud tip domain during kidney development.
Kuure S; Chi X; Lu B; Costantini F
Development; 2010 Jun; 137(12):1975-9. PubMed ID: 20463033
[TBL] [Abstract][Full Text] [Related]
28. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
[TBL] [Abstract][Full Text] [Related]
29. ETS-related transcription factors ETV4 and ETV5 are involved in proliferation and induction of differentiation-associated genes in embryonic stem (ES) cells.
Akagi T; Kuure S; Uranishi K; Koide H; Costantini F; Yokota T
J Biol Chem; 2015 Sep; 290(37):22460-73. PubMed ID: 26224636
[TBL] [Abstract][Full Text] [Related]
30. TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.
Dong J; Xiao L; Sheng L; Xu J; Sun ZQ
Asian Pac J Cancer Prev; 2014; 15(7):3099-103. PubMed ID: 24815454
[TBL] [Abstract][Full Text] [Related]
31. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
[TBL] [Abstract][Full Text] [Related]
32. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.
Paulo P; Ribeiro FR; Santos J; Mesquita D; Almeida M; Barros-Silva JD; Itkonen H; Henrique R; Jerónimo C; Sveen A; Mills IG; Skotheim RI; Lothe RA; Teixeira MR
Neoplasia; 2012 Jul; 14(7):600-11. PubMed ID: 22904677
[TBL] [Abstract][Full Text] [Related]
33. Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: a new human member of the ets oncogene family.
Higashino F; Yoshida K; Fujinaga Y; Kamio K; Fujinaga K
Nucleic Acids Res; 1993 Feb; 21(3):547-53. PubMed ID: 8441666
[TBL] [Abstract][Full Text] [Related]
34. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
35. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
36. A new member of the ETS family fused to EWS in Ewing tumors.
Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
[TBL] [Abstract][Full Text] [Related]
37. An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.
Kedage V; Selvaraj N; Nicholas TR; Budka JA; Plotnik JP; Jerde TJ; Hollenhorst PC
Cell Rep; 2016 Oct; 17(5):1289-1301. PubMed ID: 27783944
[TBL] [Abstract][Full Text] [Related]
38. Pea3 Transcription Factors, Etv4 and Etv5, Are Required for Proper Hippocampal Dendrite Development and Plasticity.
Fontanet PA; Ríos AS; Alsina FC; Paratcha G; Ledda F
Cereb Cortex; 2018 Jan; 28(1):236-249. PubMed ID: 27909004
[TBL] [Abstract][Full Text] [Related]
39. Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.
Martin ME; Yang XY; Folk WR
Mol Cell Biol; 1992 May; 12(5):2213-21. PubMed ID: 1569949
[TBL] [Abstract][Full Text] [Related]
40. [PEA3 family of transcription factors and the regulation of oncogenesis].
de Launoit Y; Baert JL; Chotteau-Lelievre A; Monte D; Coutte L; Mauen S; Firlej V; Degerny C; Verreman K
Bull Cancer; 2006 Oct; 93(10):985-9. PubMed ID: 17074657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
